2LJB image
Deposition Date 2011-09-10
Release Date 2011-11-16
Last Version Date 2024-05-15
Entry Detail
PDB ID:
2LJB
Title:
Structure of the influenza AM2-BM2 chimeric channel
Biological Source:
Host Organism:
Method Details:
Experimental Method:
Conformers Calculated:
75
Conformers Submitted:
15
Selection Criteria:
structures with the lowest energy
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:M2 protein, BM2 protein chimera
Gene (Uniprot):M
Mutagens:C19S
Chain IDs:A, B, C, D
Chain Length:35
Number of Molecules:4
Biological Source:Influenza A virus, Influenza B virus
Ligand Molecules
Primary Citation
Structural investigation of rimantadine inhibition of the AM2-BM2 chimera channel of influenza viruses.
Structure 19 1655 1663 (2011)
PMID: 22078564 DOI: 10.1016/j.str.2011.09.003

Abstact

The M2 channel of influenza A is a target of the adamantane family antiviral drugs. Two different drug-binding sites have been reported: one inside the pore, and the other is a lipid-facing pocket. A previous study showed that a chimera of M2 variants from influenza A and B that contains only the pore-binding site is sensitive to amantadine inhibition, suggesting that the primary site of inhibition is inside the pore. To obtain atomic details of channel-drug interaction, we determined the structures of the chimeric channel with and without rimantadine. Inside the channel and near the N-terminal end, methyl groups of Val27 and Ala30 from four subunits form a hydrophobic pocket around the adamantane, and the drug amino group appears to be in polar contact with the backbone oxygen of Ala30. The structures also reveal differences between the drug-bound and -unbound states of the channel that can explain drug resistance.

Legend

Protein

Chemical

Disease

Primary Citation of related structures